<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="Research Article" dtd-version="1.0"><front><journal-meta><journal-id journal-id-type="pmc">iarjp</journal-id><journal-id journal-id-type="pubmed">IARJP</journal-id><journal-id journal-id-type="publisher">IARJP</journal-id><issn>2709-9512</issn></journal-meta><article-meta><article-id pub-id-type="doi">https://doi.org/10.47310/iarjp.2023.v04i02.013</article-id><title-group><article-title>Evaluation of Thiosemicarbazones Compound derivatives as Antitumor</article-title></title-group><contrib-group><contrib contrib-type="author"><name><given-names>Ahmed</given-names><surname>Al-Talaqani</surname></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><given-names>Dunya</given-names><surname>Al-Duhaidahawib</surname></name></contrib></contrib-group><aff-id id="aff-a" /><abstract>Thiosemicarbazones (TSCs), antiviral, antibacterial, antitubercular, antiprotozoal, antimalarial, antifungal, enzyme inhibitory,</abstract></article-meta></front><body /><back /></article>